INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 256 filers reported holding INARI MED INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,198,408 | +9.9% | 951,046 | -2.3% | 0.03% | +10.7% |
| Q2 2023 | $56,589,232 | +214782.2% | 973,327 | +128.2% | 0.03% | +75.0% |
| Q1 2023 | $26,335 | +452.9% | 426,541 | +469.2% | 0.02% | +700.0% |
| Q4 2022 | $4,763 | -100.0% | 74,936 | -85.7% | 0.00% | -90.9% |
| Q3 2022 | $38,088,000 | +83.1% | 524,340 | +71.4% | 0.02% | +69.2% |
| Q2 2022 | $20,800,000 | -63.2% | 305,930 | -50.9% | 0.01% | -55.2% |
| Q1 2022 | $56,495,000 | +84.0% | 623,292 | +85.3% | 0.03% | +81.2% |
| Q4 2021 | $30,707,000 | +45.6% | 336,445 | +29.4% | 0.02% | +33.3% |
| Q3 2021 | $21,093,000 | -46.7% | 260,081 | -38.7% | 0.01% | -52.0% |
| Q2 2021 | $39,600,000 | -50.8% | 424,520 | -43.6% | 0.02% | -56.9% |
| Q1 2021 | $80,496,000 | +25.9% | 752,298 | +2.7% | 0.06% | +26.1% |
| Q4 2020 | $63,922,000 | +5807.8% | 732,296 | +3179.4% | 0.05% | +4500.0% |
| Q2 2020 | $1,082,000 | – | 22,330 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |